Johnson & Johnson
JNJ
₹13,341
Share price
2.08%
Change (1 day)
9.13%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Johnson & Johnson (JNJ) - Total assets
Total assets on the balance sheet as of March 2025 : ₹16.570 Trillion
According to Johnson & Johnson's latest financial reports the company's total assets are ₹16.570 Trillion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Johnson & Johnson - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | ₹15.450 T | 10.76% |
| 2023-12-31 | ₹13.949 T | -10.04% |
| 2022-12-31 | ₹15.505 T | 14.45% |
| 2021-12-31 | ₹13.547 T | 5.92% |
| 2020-12-31 | ₹12.790 T | 13.72% |
| 2019-12-31 | ₹11.247 T | 5.17% |
| 2018-12-31 | ₹10.694 T | 6.48% |
| 2017-12-31 | ₹10.043 T | 4.67% |
| 2016-12-31 | ₹9.595 T | 8.23% |
| 2015-12-31 | ₹8.865 T | 7.31% |
| 2014-12-31 | ₹8.261 T | 0.79% |
| 2013-12-31 | ₹8.197 T | 23.37% |
| 2012-12-31 | ₹6.644 T | 10.52% |
| 2011-12-31 | ₹6.011 T | 30.37% |
| 2010-12-31 | ₹4.611 T | 4.96% |
| 2009-12-31 | ₹4.393 T | 7.64% |
| 2008-12-31 | ₹4.081 T | 28.46% |
| 2007-12-31 | ₹3.177 T | 1.67% |
| 2006-12-31 | ₹3.124 T | 17.97% |
| 2005-12-31 | ₹2.648 T | 14.72% |
| 2004-12-31 | ₹2.309 T | 5.08% |
| 2003-12-31 | ₹2.197 T | 12.99% |
| 2002-12-31 | ₹1.944 T | 4.72% |
| 2001-12-31 | ₹1.857 T |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | ₹17.798 T | 7.41% | 🇺🇸 USA |
 Merck MRK | ₹9.849 T | -40.56% | 🇺🇸 USA |
 Novartis NVS | ₹8.550 T | -48.40% | 🇨🇭 Switzerland |
 Sanofi SNY | ₹12.208 T | -26.32% | 🇫🇷 France |
 Stryker Corporation SYK | ₹3.936 T | -76.25% | 🇺🇸 USA |
 Medtronic MDT | ₹7.698 T | -53.54% | 🇮🇪 Ireland |
 Eli Lilly LLY | ₹7.648 T | -53.85% | 🇺🇸 USA |
 Abbott Laboratories ABT | ₹6.968 T | -57.95% | 🇺🇸 USA |
 GlaxoSmithKline GSK | ₹6.711 T | -59.50% | 🇬🇧 UK |
 Gilead Sciences GILD | ₹4.828 T | -70.86% | 🇺🇸 USA |